Dr. Suhayl Dhib-Jalbut is Professor and Chairman of the Department of Neurology at RUTGERS-Robert Wood Johnson Medical School and Director of the RWJ Center for Multiple Sclerosis (MS). Dr. Dhib-Jalbut currently serves as President of the Americas Committee for Treatment and Research in MS (ACTRIMS).
Dr. Dhib-Jalbut graduated Alpha-Omega-Alpha from the American University of Beirut in Lebanon and completed his Neurology training at the University of Cincinnati. He then joined the National Institutes of Health (NIH) in Bethesda, Maryland where he specialized in MS and Neuroimmunology. Dr. Dhib-Jalbut was a faculty member of the University of Maryland before his recruitment to Robert Wood Johnson Medical School in 2003.
Dr. Dhib-Jalbut’s research, which has been funded by the NIH, The National MS Society, and Industry, include how MS therapies work, biomarkers of treatment response in MS, and neuroprotective gene therapy. Dr. Dhib-Jalbut published over 130 manuscripts in the scientific literature. He served as Associate Editor for the Journal of Neuroimmunology. He currently serves as Associate Editor for the MS Journal and is a member of the Editorial Boards of JICR, Cytokine, and MS International. He served on several National and International scientific committees including Chairmanship of the Scientific Committee for the World Congress on MS in 2008. Dr. Dhib-Jalbut has been on the Best Doctors in America list since 2009 and has received several awards and recognitions. Most recently he was awarded the Norman H. Edelman clinical science mentoring award at RUTGERS, the Medical Excellence Award by the National MS Society NJ Metro Chapter, the Edward Ill Award for Excellence in clinical research in the State of New Jersey and the NJ Foundation Excellence in Research Award.